已收录 268921 条政策
 政策提纲
  • 暂无提纲
Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring
[摘要] This prospective, cross-over, blinded study evaluated the effect of various doses of phenylpropanolamine (PPA) on blood pressure in dogs. Dogs were randomized to receive a placebo or 1 of 3 dosages of immediate release PPA, q12h for 7 days [1 mg/kg body weight (BW), 2 mg/kg BW, or 4 mg/kg BW] in a cross-over design. Blood pressure was recorded every 2 h, for 12 h, on days 1 and 7. There were significant increases in systolic, diastolic, and mean blood pressure following administration of PPA at 2 mg/kg BW and 4 mg/kg BW. A significant decrease in heart rate was also noted at all PPA dosages, but not in the placebo. Administration of PPA was associated with a dose response increase in blood pressure. Dosages of up to 2 mg/kg BW should be considered safe in healthy dogs.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 兽医学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文